There has long been evidence that hepatitis C can lead to persistent infection in a high
proportion of infected individuals, and can progress to chronic liver disease, cirrhosis and …

The diagnosis and treatment of hepatocellular carcinoma (HCC) have witnessed major
changes over the past decade. Until the early 1990s, HCC was a relatively rare malignancy …

Purpose Hepatocellular carcinoma (HCC) is the third leading cause of cancer mortality
worldwide. Incidence rates are increasing in the United States. Monitoring incidence …

Primary liver cancer (PLC) represents approximately 4% of all new cancer cases diagnosed
worldwide. The purpose of this review is to describe some of the latest international patterns …

Downstaging can facilitate liver transplantation (LT) for patients outside of Milan criteria with
hepatocellular carcinoma (HCC); however, the optimal protocol and downstaging outcomes …

Hepatocellular carcinoma (HCC) is the third most common cause of death from cancer. The
incidence and mortality of HCC are increasing in most Western countries as a result of an …

Surveillance for hepatocellular carcinoma (HCC) in patients with cirrhosis is recommended
but may not be performed. The extent and determinants of HCC surveillance are unknown …

Hepatocellular carcinoma (HCC), the most common primary malignancy of the liver,
represents 1 of the leading causes of cancer deaths in the world with an estimated 21,670 …

Purpose To conduct a large single-institution comparison of transarterial chemoembolization
(TACE) and stereotactic body radiation therapy (SBRT) outcomes in similar groups of …

OBJECTIVES: Hepatocellular carcinoma (HCC) surveillance with biannual ultrasound is
currently recommended for all patients with cirrhosis. However, clinical implementation of …